Fansidar resistant Plasmodium falciparum infection in Surinam.
The first cases of Fansidar resistant Plasmodium falciparum infection in Surinam are reported after chloroquine-resistance was reported in 1972. The resistant cases were suspected by physicians and confirmed after performing the 35-day extended standard WHO 7-day in vivo-test. The distribution of drug resistant P. falciparum in Surinam is presented. The problem that drug resistance causes in the Malaria Eradication Program in Surinam is discussed.
D000962:Antimalarials / Q000627:therapeutic use*; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010963:Plasmodium falciparum / Q000187:drug effects; D011739:Pyrimethamine / Q000494:pharmacology / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000494:pharmacology / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*; D013532:Suriname
D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine